Locker C, Shapira I, Paz Y, Kramer A, Gurevitch J, Matsa M, Pevni D, Mohr R
Department of Thoracic and Cardiovascular Surgery, Tel Aviv Sourasky Medical Center, 6 Weizman St., Tel-Aviv, Israel.
Eur J Cardiothorac Surg. 2000 Mar;17(3):234-8. doi: 10.1016/s1010-7940(00)00354-7.
Emergency coronary artery bypass grafting (CABG) for acute myocardial infarction (AMI) is associated with increased operative mortality. It has been suggested that this mortality might be reduced by performing the operation without cardiopulmonary bypass (CPB).
Between January 1992 and April 1998, 77 patients underwent emergency CABG within 48 h of AMI. Thirty seven were operated on with CPB, and 40 without CPB. The two groups were similar regarding age, gender, left-ventricular ejection fraction (EF) and preoperative use of intra-aortic balloon pump (IABP; 50%). The mean number of grafts/patient was 3 in the CPB group, and 1.9 in the No-CPB group (P<0.0001).
Operative mortality in the CPB group was 24% (nine of 37) compared to 5% (two of 40) without CPB (P=0.015). Follow-up ranged between 6 and 66 months. There were no late deaths in the CPB group compared to nine (22%) in the No-CPB group (P<0.0066). Patients operated on with CPB had lower rates of recurrent angina (0 versus 15%; P=0.04) and re-interventions (0 versus 15%; P=0.04).
Our experience suggests that CABG without CPB is the preferred method of myocardial revascularization, due to the fact that it carries lower mortality than CABG with CPB. The trade-off includes increased rates of recurrent angina, re-interventions and late mortality.
急性心肌梗死(AMI)患者行急诊冠状动脉旁路移植术(CABG)与手术死亡率增加相关。有人提出,不使用体外循环(CPB)进行手术可能会降低这种死亡率。
1992年1月至1998年4月期间,77例患者在AMI发病48小时内行急诊CABG。37例患者在CPB辅助下进行手术,40例患者未使用CPB。两组在年龄、性别、左心室射血分数(EF)和术前主动脉内球囊反搏(IABP)的使用情况(50%)方面相似。CPB组患者平均移植血管数为3根,非CPB组为1.9根(P<0.0001)。
CPB组手术死亡率为24%(37例中有9例),而未使用CPB组为5%(40例中有2例)(P=0.015)。随访时间为6至66个月。CPB组无晚期死亡病例,而非CPB组有9例(22%)(P<0.0066)。接受CPB手术的患者复发性心绞痛发生率较低(0%对15%;P=0.04),再次干预率也较低(0%对15%;P=0.04)。
我们的经验表明,不使用CPB的CABG是心肌血运重建的首选方法,因为其死亡率低于使用CPB的CABG。权衡之处包括复发性心绞痛、再次干预和晚期死亡率增加。